Trials / Sponsors / Spur Therapeutics
Spur Therapeutics
Industry · 8 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Gaucher Disease Gene Therapy Trial With FLT201 Gaucher Disease Type 1 | Phase 3 | 2026-07-01 |
| Active Not Recruiting | Long Term Follow-up Study of Type-1 Gaucher Subjects Post FLT201 Dose (GALILEO-2) Gaucher Disease, Type 1 | Phase 1 / Phase 2 | 2024-05-13 |
| Completed | A Gene Therapy Study in Patients With Gaucher Disease Type 1 Gaucher Disease, Type 1 | Phase 1 | 2022-04-15 |
| Terminated | Phase 1/2 Dose Confirmation Study of FLT180a in Hemophilia B Hemophilia B | Phase 1 / Phase 2 | 2021-12-06 |
| Completed | A Long Term Follow-Up Study of Fabry Disease Subjects Treated With FLT190 Fabry Disease, Lysosomal Storage Diseases | Phase 1 / Phase 2 | 2020-09-08 |
| Completed | AAV Gene Therapy Screening/Observational Protocol (ECLIPSE) Hemophilia B, Blood Coagulation Disorders, Inherited, Blood Coagulation Disorder | — | 2020-02-14 |
| Terminated | A Fabry Disease Gene Therapy Study Fabry Disease, Lysosomal Storage Diseases | Phase 1 / Phase 2 | 2019-07-08 |
| Terminated | A Long-Term Follow-Up Study of Haemophilia B Patients Who Have Undergone Gene Therapy Hemophilia B | Phase 1 / Phase 2 | 2018-07-10 |